首页> 外文期刊>Seminars in liver disease >Treatment of patients with cirrhosis and ascites.
【24h】

Treatment of patients with cirrhosis and ascites.

机译:肝硬化和腹水患者的治疗。

获取原文
获取原文并翻译 | 示例
       

摘要

The treatment of patients with cirrhosis and fluid overload has undergone substantial change in recent years, because of new information regarding old treatments, as well as new treatments. The goals of treatment are to maximize life expectancy and quality of life. Development of ascites is a landmark in the natural history of cirrhosis signaling poor life expectancy, in general. Patients who are appropriate candidates for liver transplantation should undergo evaluation for this procedure after development of ascites. Patients awaiting transplantation as well as non-candidates for this procedure should be managed by restriction of dietary sodium and prescription of diuretics. This approach is effective in controlling fluid overload in > 90% of patients. Only the 10% who fail this simple medical treatment should be considered for second-line therapy.
机译:近年来,由于有关旧疗法的新信息以及新疗法,肝硬化和液体超负荷患者的治疗发生了重大变化。治疗的目标是使预期寿命和生活质量最大化。通常,腹水的形成是肝硬化自然史上的一个里程碑,标志着预期寿命的延长。腹水形成后,适合肝移植的患者应对此程序进行评估。等待移植的患者以及非候选患者应通过限制饮食中的钠盐和利尿剂的处方来治疗。这种方法可有效控制90%以上的患者的液体超负荷。只有10%的患者因这种简单的药物治疗失败而应考虑进行二线治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号